Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab

• Lucy B. M. Cook,
• Maria Antonietta Demontis,
• Sophie Sagawe,
• Aviva Witkover,
• Anat Melamed,
• Jocelyn Turpin,
• Richard Dillon,
• Jana Haddow,
• Alexandra J. Marks,
• Charles R. M. Bangham,
• Paul Fields,
• Graham P. Taylor,
• Aileen G. Rowan

Affiliations

Lucy B. M. Cook

Section of Virology, Department of Medicine, Imperial College London;Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital;National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, St Mary’s Hospital, London

Maria Antonietta Demontis

Skin Tumour Unit, Guys’ Hospital, Great Maze Pond, London

Sophie Sagawe

Section of Virology, Department of Medicine, Imperial College London

Aviva Witkover

Section of Virology, Department of Medicine, Imperial College London

Anat Melamed

Section of Virology, Department of Medicine, Imperial College London

Jocelyn Turpin

Section of Virology, Department of Medicine, Imperial College London

Richard Dillon

Department of Haematology, Guys’ Hospital, Great Maze Pond, London, UK

Jana Haddow

National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, St Mary’s Hospital, London

Alexandra J. Marks

Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital

Charles R. M. Bangham

Section of Virology, Department of Medicine, Imperial College London

Paul Fields

Department of Haematology, Guys’ Hospital, Great Maze Pond, London, UK

Graham P. Taylor

Section of Virology, Department of Medicine, Imperial College London;National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, St Mary’s Hospital, London

Aileen G. Rowan

Section of Virology, Department of Medicine, Imperial College London